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Abstract
Myo1c is one of eight members of the mammalian myosin I family of actin-associated molecular
motors. In stereocilia of the hair cells in the inner ear, Myo1c presumably serves as the adaptation
motor, which regulates the opening and closing of transduction channels. Although there is
conservation of sequence and structure among all myosins in the N-terminal motor domain, which
contains the nucleotide- and actin-binding sites, some differences include the length and composition
of surface loops, including loop 1, which lies near the nucleotide-binding domain. To investigate the
role of loop 1, we expressed in insect cells mutants of a truncated form of Myo1c, Myo1c1IQ, as well
as chimeras of Myo1c1IQ with the analogous loop from other myosins. We found that replacement
of the charged residues in loop 1 with alanines or the whole loop with a series of alanines did not
alter the ATPase activity, transient kinetics properties and Ca2+-sensitivity of Myo1c1IQ. Substitution
of loop 1 with that of the corresponding region from tonic smooth muscle myosin II (Myo1c1IQ-
tonic) or replacement with a single glycine (Myo1c1IQ-G) accelerated ADP release from A.M 2-3-
fold in Ca2+, whereas substitution with loop 1 from phasic muscle myosin II (Myo1c1IQ-phasic)
accelerated ADP release 35-fold. Motility assays with chimeras containing a single α-helix, or SAH,
domain showed that Myo1cSAH-tonic translocated actin in vitro twice as fast as Myo1cSAH-WT and
3-fold faster than Myo1cSAH-G. The studies show that changes induced in Myo1c by modifying loop
1 showed no resemblance to the behaviour of the loop donor myosins or to the changes previously
observed with similar Myo1b chimeras.
Myosins are a large family of molecular motors that have been subdivided into more than 30
subgroups (1,2). Different family members are involved in a wide range of motor activities in
eukaryotic cells such as muscle contraction, cell division, pseudopod extension and vesicle
transport (3,4). Class I myosins are a diverse group of monomeric myosins implicated in several
actin-mediated processes including organization and maintenance of tension of the
cytoskeleton as well as signal transduction (5-7). The mammalian class I myosin, Myo1c,
consists of a heavy chain containing an N-terminal motor domain, a neck or lever arm stabilised
by 3 calmodulin molecules and a C-terminal tail region implicated in membrane binding
(8-10). Myo1c mediates the cycling of GLUT4 transporters in adipocytes by promoting the
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fusion of GLUT4-containing vesicles with the cell membrane (11-13). In the specialized hair
cells of the inner ear, Myo1c is believed to be the adaptation motor, which regulates the tension
on the tip links that connect neighbouring stereocilia thereby controlling the opening and
closing of transduction channels (5).
We recently defined the biochemical kinetics of the ATP-driven interaction of Myo1c with
actin and showed that it has an unusual calcium dependence (14). Calcium binding to the
calmodulin closest to the motor domain has little effect on the ATPase or motor activity, but
alters specific steps of the ATPase cycle. ATP hydrolysis was inhibited 7-fold by calcium while
ADP release from acto-Myo1c was accelerated by 10-fold. These two changes together would
reduce the lifetime of the actin-attached states and increase the lifetime of the actin-detached
state without altering the overall cycle time. In combination these properties appear to be ideal
to modulate the activity of Myo1c in response to a calcium transient of the sort expected to
occur in the inner ear.
The observation that certain events in the ATPase cycle are regulated oppositely in calcium is
curious and in particular the Ca2+-regulation of the ATP hydrolysis step has not been reported
previously for any myosin. This raises the question of whether the ATP hydrolysis step is
controlled by calcium binding to the calmodulin light chain. In fact, the regulation may occur
via the myosin conformational change that precedes the ATP cleavage step and is thought to
position the catalytic residues to allow ATP splitting. This conformational change, known as
the recovery stroke, involves the movement of switch II and the accompanying converter-
domain movement to reprime the lever arm/light-chain domain (15,16). Thus, the recovery
stroke results in a repositioning of the light chains and therefore could be influenced by a
calcium-induced change in the calmodulin/light chain conformation.
Other events regulated by calcium are ATP binding and ADP release. ADP release in smooth
and scallop muscle is altered via phosphorylation or calcium binding to light chains (17,18).
The exact mechanism by which the conformation of the light chains is communicated to the
nucleotide-binding pocket for these dimeric myosins is not defined, but may involve some
form of interaction between the two motor domains facilitated by the conformation of the neck
domains (19-21). Although we previously reported a modest regulation of nucleotide release
in calcium for the related myosin I, Myo1b, the behaviour of Myo1c is more dramatic (22).
The communication pathway of this novel regulation via the light chains for monomeric
myosins is unknown.
The structure of the myosin motor domain is highly conserved across the broad myosin family;
however, there are several surface loops that are less well conserved. These loops have been
proposed to tune the activity of myosins to their specific cellular roles (23). One such loop is
loop 1 near the entrance to the nucleotide-binding pocket. Loop 1 joins two helices, one
connected to switch 1 and the other to the P-loop. These two elements form a major part of the
binding site for the gamma phosphate in ATP. Loop 1 is therefore in a position to influence
access to the nucleotide pocket and the interaction with the gamma Pi of ATP. Previous studies
of natural variations of loop 1 in vertebrate smooth muscle myosin II (24-26) have shown that
alternately expressed loops can alter the release of ADP from the nucleotide pocket.
Furthermore, studies on scallop muscle myosin II (27) have established that alternate splicing
of loop 1 alters the affinity of acto-myosin for ADP thereby permitting the cell to produce
myosins with differing ATPase and motility properties. However, studies of engineered
variations in the size and composition of loop 1 in either a smooth muscle myosin II or a
Dictyostelium myosin II (28) have so far failed to resolve which features of loop 1 are
responsible for this modulation of myosin activity.
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Goodson and colleagues showed that the sequences of loop 1 are well conserved when myosins
are grouped according to their kinetic activity and proposed that loop 1 modulates the kinetic
characteristics that distinguish one myosin isoform from another (29). It has also been
suggested that the flexibility of loop 1 or its length determines activity (26) and that longer
loops interact with other parts of the myosin molecule including the light chains in some
conformations thereby affecting regulation (30).
In a previous study (22), we explored the role of loop 1 on Myo1b by replacing its charged
residues with alanine, the whole loop with alanine residues or replacing the loop with either a
single glycine, or loop 1 from either phasic or tonic smooth muscle myosin II, a strategy similar
to that used by others to explore the effects of loop 1 on smooth muscle myosin II (24,26,27).
We found that loop 1 had major effects on the coupling of actin and nucleotide-binding events
in Myo1b and that it is likely to modulate the load dependence of Myo1b. The role of loop 1
can therefore have broad implications for modulating myosin motor activity; however, the
same mutations in different myosin backgrounds can have quite different effects (22,31).
To explore the role of loop 1 in Myo1c we investigated how loop 1 modulates the motor activity
of Myo1c, specifically its effects on nucleotide binding and release in the presence and absence
of calcium. We found that all the results obtained with the Myo1c chimeras stand in marked
contrast to those previously obtained with similar constructs using Myo1b.
Experimental Procedures
Preparation of Constructs and Expression in Insect Cells
Using cDNA encoding the entire open reading frame of Myo1c (previously known as myr 2;
the kind gift of Dr. Martin Bähler; Institut für Allgemeine Zoologie und Genetik, Westfälische-
Wilhelms Universität, Münster, Germany), we prepared a series of constructs in which loop 1
of Myo1c1IQ, a truncated form of rat Myo1c representing the motor domains and first IQ
domain (amino acids 1-725) (32), was replaced with loops 1 from other myosins; or in which
alanine substitutions were made in the endogenous loop 1. To define the beginning and end of
loop 1 in Myo1c, secondary structure assignments were made by the program DSSP (Definition
of Secondary Structure of Protein; http://swift.cmbi.ru.nl/gv/dssp/descrip.html). All mutants
except Myo1c1IQ-phasic were created using polymerase chain reaction (PCR). Overlapping
sets of primers having the desired mutations and restriction sites and incorporating a FLAG
tag at the C-terminus were used in the first set of PCR reactions. The two resulting fragments
were then subjected to another round of PCR with the outside primers to generate the in-frame
fusion proteins. After treatment with the appropriate restriction enzymes, the purified PCR
products were ligated into the pFastBacDUAL transfer vector (Gibco BRL, Gaithersburg, MD)
downstream of the polyhedrin promoter; the p10 promoter cloning site contained the gene
coding for calmodulin (32). The plasmids were transformed into DH5α cells and selected by
antibiotic resistance. Colonies were grown and the isolated DNA was tested for the presence
of inserts by restriction analysis. Plasmids containing Myo1c inserts were sequenced with
internal and vector-specific oligonucleotides using automated sequencing. Myo1c1IQ-phasic
was made using the Transformer Site-Directed Mutagenesis Kit (Clontech, Mountain View,
CA 94043). Briefly, a mutagenic primer and a selection primer were used to generate a mixture
of mutated and unmutated plasmids. The mixture was then subjected to a selective restriction
digestion, which selectively digested the unmutated plasmid. The mutated plasmid was then
transformed as above into DH5α followed by selection according to antibiotic resistance.
Plasmids were isolated from selected colonies and those containing inserts were subjected to
automatic sequencing.
In all cases, the recombinant donor plasmid was transformed into DH10Bac E. coli cells
(Invitrogen, Carlsbad, Ca 92008) for transposition into bacmid. Recombinant bacmid DNA
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was isolated by potassium acetate precipitation as described by the Bac-to-Bac Baculovirus
Expression Systems Instruction Manual supplied by Invitrogen. Virus was produced by
transfecting the recombinant bacmid DNA into Spondoptera frugiperda 9 (Sf9) insect cells
with Cellfectin reagent (Invitrogen) followed by 3 days of growth. Subsequently, amplified
virus was used to infect Sf9 cells in suspension. Infection was allowed to proceed for 4 days
after which time cells were harvested by centrifugation. Cell pellets were either used
immediately for protein isolation or frozen in liquid N2 and stored at -80°C for future use.
Protein purification
To isolate protein, the insect cell pellets were homogenized in 10 mM Tris, pH 7.5, 0.2 M
NaCl, 4 mM MgCl2, and 2 mM ATP in the presence of protease inhibitors and then centrifuged
at 183,000 × g for 50 min. The supernatant was applied to an anti-FLAG column, and after
washing the expressed proteins were eluted with a step gradient of FLAG peptide. Fractions
containing protein were identified by SDS-polyacrylamide gel electrophoresis, pooled and
dialyzed against 10 mM Tris, 50 mM KCL and 1 mM DTT. Proteins were either used
immediately or stored at -80°C for future use.
Preparation of Constructs with a SAH Domain
Using the clone for rat myosin X (kindly provided by Drs. Erich Boger and Thomas Friedman,
NIDCD, NIH) we prepared by PCR a fusion construct (Myo1cSAH-WT) in which the SAH
domain of myosin X (amino acids 805-843) followed by a myc and FLAG tag were added to
wild-type Myo1c at residue 762 based on sequence analogy between Myo1c and myosin X as
determined by Clustal X. This results in a LCBD consisting of two complete IQ motifs and
most of the third IQ motif followed by the SAH domain. The SAH constructs express in insect
cells at levels equivalent to the 1IQ forms. Similar constructs for the loop 1 mutants, tonic,
phasic and G (Myo1cSAH-tonic, Myo1cSAH-phasic and Myo1cSAH-G, respectively) were also
prepared and expressed in insect cells and purified by affinity purification with anti-FLAG.
ATPase Activity
The steady-state actin-activated Mg2+-ATPase activity of Myo1c and the loop 1 mutants (1IQ
forms and those incorporating SAH domains) was measured using a colorimetric assay
described by Pollard (33) in 10 mM Tris, pH 7.5, 50 mm KCl, 1 mM MgCl2 and CaCl2 and
EGTA to effect pCa values ranging from 4 - 8.9.
Motility Assays
The ability of the purified myosins to translocate actin filaments in vitro was determined using
a procedure similar to one previously described (34). Briefly, flow chambers were made by
attaching nitrocellulose-coated coverslips face down to a glass microscope slide using double-
sided sticky tape. Myosin was prepared by mixing it with 0.05 mg/ml F-actin and 10 mM ATP
for 20 min, then spinning at 245,00 × g and 4°C for 20 min. The flow chambers were coated
with ∼12 μl 0.05 mg/ml myc antibody (Invitrogen) in PBS for 15 min, then 75 μl 5 mg/ml
bovine serum albumin (BSA) in motility buffer (25 mM Imidazole, pH 7.5, 1 mM EGTA, 25
mM KCL, 4 mM MgCl2) for 10 min to block non-specific sites. Thirty μl myosin supernatant
(at various concentrations) was applied to the flow chamber for 15 min then washed with
motility buffer plus BSA for 10 min. Thirty μl ∼0.14 μM rabbit skeletal muscle F-actin labeled
with rhodamine phalloidin (Molecular Probes, Eugene, OR) was applied to the flow chamber
for 5 min. The chambers were washed with 75 μl motility buffer plus BSA before adding 50
μl motility buffer containing 0.5% methylcellulose, 3 mg/ml glucose, 20 mM DTT, 0.1 mg/ml
glucose oxidase, 0.05 mg/ml catalase and 2 mM ATP. Slides were examined with a
fluorescence microscope using a 100× oil immersion lens (Nikon Inc., Melville, NY). Images
were recorded digitally using a FlashBus MV PCI bus frame grabber (Integral Technologies,
Adamek et al. Page 4













Inc., Indianapolis, IN). The percentage of translocating filaments was determined using
Manually Count Objects, and the speed of the filaments was determined using Track Points in
MetaMorph bioimaging software (version 6.3r2, Universal Imaging Corp., Downingtown,
PA).
Transient enzyme kinetics
Rapid kinetic measurements were carried out using a standard Hi-Tech Scientific SF-61 DX2
stopped-flow system fitted with a 75 W Xe/Hg lamp and monochromator for wavelength
selection. Intrinsic tryptophan fluorescence was excited at 295 nm and emission monitored
through a WG320 cut-off filter, while pyrene fluorescence was excited at 365 nm and emission
monitored through a KV 398 nm cut-off filter. The stopped-flow transients were fitted to one
or two exponentials as described previously by non-linear least squares curve fitting using the
Kinetic Studio software (TgK Scientific). The reactant concentrations stated in the text and
figures are those after 1:1 mixing in the stopped-flow spectrophotometer, unless stated
otherwise. In some secondary data plots the plotted concentrations are those prior to mixing,
which are then indicated as ‘initial [X]’. All experiments were carried out at 20°C in 20 mM
MOPS buffer containing 100 mM KCL, and 5 mM MgCl2. In addition the buffer contained
either 1 mM EGTA for measurements without calcium, or 1.1 mM EGTA and 1.2 mM
CaCl2 for measurements carried out in the presence of calcium.
Data Analysis
In the absence of actin the interaction of ATP and ADP with Myo1c was interpreted in terms
of the 7-step mechanism for the myosin ATPase cycle (see Scheme 2) in which ATP binding
to myosin occurs in two steps (a binding step and a protein conformational change followed
by reversible ATP hydrolysis (35,36)). Pi release and ADP release then occur sequentially,
each dissociation event preceded by a protein isomerisation. Our previous work established
that ATP binding is accompanied by an increase in tryptophan fluorescence and there is no
fluorescence change associated with ADP binding (14). We assume this fluorescence change
is associated with the hydrolysis step because Myo1c has the conserved tryptophan at the end
of the relay loop, which is known to signal the protein conformational change associated with
switch II closure and the hydrolysis step in other myosins. The rate constant for the step
(k+3+k-3) was inhibited 7-fold by calcium for Myo1c1IQ-WT.
The results of the kinetic interaction of actin-Myo1c1IQ with nucleotide were interpreted in
terms of the model we described previously for Myo1b (37) and Myo1c (5,14) (Scheme 1).
The model assumes that acto-Myo1c exists in two conformations, A.M and A.M′, in the absence
of nucleotide and that the interconversion between the two conformations is defined by the
equilibrium constant Kα (Kα = k+α / k-α). A.M′ represents the complex with the nucleotide
pocket in the “closed” conformation which must isomerise into the “open-pocket” form, A.M,
before nucleotide binding/release can occur. This isomerisation is believed to be coupled to a
swing of the converter/IQ regions of the myosin motor domain. The ATP-induced dissociation
of actin-myosin is biphasic. The fast phase represents ATP binding to A.M and the observed
rate constant is hyperbolically dependent upon ATP concentration with kobs,fast = K1k+2[ATP]/
(1+K1[ATP]).
The kobs for the slow phase also shows hyperbolic dependence upon ATP concentration for
Myo1c1IQ-WT. This is unusual but reflects the fact that A.M′ is the predominant species present
(Kα <1). An exact solution to the ATP dependence of the slow phase is not possible but three
regions of the ATP dependent behaviour of the slow phase can be described that depend upon
the relative rate constants of ATP binding to A.M and the isomerisation of A.M′ to A.M. At
very high [ATP] if k-α ≪ than the rate of ATP binding (K1k+2[ATP]/(1+K1[ATP])) then every
A.M′ that isomerises to A.M will bind ATP irreversibly and lead to dissociation of the myosin
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from the complex. Under these conditions the kobs has it maximal value and kmax,slow = k+α.
For WT Myo1c then k+2 is more than ten times the maximum observed value of the slow phase
and therefore the conditions are valid and kmax,slow = k+α.
At very low [ATP], such that K1[ATP]≪1, the kobs of ATP binding to A.M is K1k+2[ATP],
and if this is slow compared to k-α + k+α then only a single phase will be observed. The kobs
is then defined as K1k+2[ATP]/(1+ Kα), the rate constant for ATP binding to A.M times the
fraction of acto-Myo1c in the A.M conformation (= 1/ (1+ Kα)). This condition will always be
fulfilled if the ATP concentration is low enough. The estimated value of k-α + k+α for the WT
is 20-25 s-1 independent of the presence of calcium and therefore this condition will be met at
[ATP]≪ 1 mM.
If k-α + k+α is of the same order as the fast phase then the observed slow phase will depend
upon the relative rate constants of k-α and the rate constant of ATP binding (K1k+2[ATP]/(1
+K1[ATP])). The half maximal value of the kobs for the slow phase will be observed at the
ATP concentration (K0.5) when (K1k+2[ATP]/(1+K1[ATP])) = k-α. Since k-α can be calculated
from Kα (obtained from the relative amplitude of the fast and slow phases) and k+α =
kmax, slow, then the value of K0.5 can be predicted.
Two similar complexes are also assumed to exist in the presence of ADP, A.M.D and A.M′.D,
with an open and closed nucleotide pocket, respectively. In the case of Myo1c1IQ-WT the
binding and release of ADP from A.M.D and A.M′.D cannot be distinguished because the rate
constants governing ATP binding are slower than ADP release. The apparent ADP affinity can
be estimated by measuring the ADP inhibition of the ATP-induced dissociation of acto-myosin.
In the case of Myo1c1IQ-WT, ADP is in rapid equilibrium with A.M and A.M′ on the time
scale of the slow phase of the reaction. Thus, the slow phase, kobs, is reduced with a hyperbolic
dependence upon ADP concentration (independent of whether the ADP is premixed with the
protein or the ATP) and K0.5 = (KAD/(1 + 1/Kα), where KAD is the affinity of A.M for ADP.
The observed behaviour of the ATP-induced dissociation reaction and the ADP inhibition of
the slow phase are similar in the presence or absence of calcium, although the rate and
equilibrium constants change. This is not the case for the fast phase of the dissociation reaction,
which appears different in the presence and absence of ADP. The fast phase is small and
difficult to characterise in the presence of ADP. When ADP is pre-incubated with the protein,
the small amplitude of the fast phase decreases and cannot be measured at ADP concentrations
above 5 μM. If ADP is pre-incubated with the ATP before mixing with protein then the
observed behaviour is different in the presence vs. absence of calcium. In the absence of
calcium the system behaves as though the ADP is in rapid equilibrium with A.M and A.M′,
i.e., ADP binding and release is much faster than the rate constants for ATP binding
(K1k+2[ATP]) and ADP slows the kobs with 50% inhibition when [ADP] = KAD. If calcium is
not present then the kobs increases linearly with ADP concentration (38). This is consistent
with the rate constant of ADP and ATP binding being of the same size and once ADP binds it
is only released slowly. In this case, kobs = K1k+2[ATP] + k-AD[ADP], and in a plot of kobs vs
[ADP] the slope of the linear fit equals the second order binding rate constant k-AD and the
intercept equals K1k+2[ATP] (39,40). We therefore see a change in the behaviour from
inhibition of ATP-induced dissociation of A.M by ADP in the absence of calcium to a 10-fold
acceleration of the rate constant for ADP release (k+AD) in calcium. Thus calcium alters the
relative values ofK1k+2[ATP] and k+AD.
Results
There are two clear phases of the changes in pyrene fluorescence when ATP is rapidly mixed
with pyr.actin-Myo1c1IQ; a large slow phase and a small fast phase (50 % and 6 % amplitude,
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respectively). The hyperbolic dependence of the fast phase in the absence of calcium was
resolved (Figure 2) in contrast to our earlier work on the wild type, which could only resolve
the data in the presence of calcium (14). The data in the presence of calcium are identical to
this earlier work. The results are summarized in Table 3 and show that the removal of calcium
accelerates the maximum kobs (k+2) from 19.6 s-1 to 41.2 s-1 while the K0.5 (1/K1) values
decrease from 1.6 mM to 0.51 mM. Thus, calcium alters both the equilibrium constant for ATP
binding and the isomerisation step, thought to be coupled to switch I movement (41). The steps
sensitive to calcium are therefore: the ATP hydrolysis step, which is inhibited 7-fold by
calcium; the ADP release from acto-myosin, which is activated 10-fold by calcium; and the
ATP-induced dissociation of AM, in which the maximum rate constant is inhibited 2-fold and
the ATP concentration for half maximal inhibition is increased 3-fold by calcium. This differs
from all the other myosins that show calcium regulation. These have all been reported to have
Ca2+-dependence primarily of Pi-release and ADP binding and release events (22,42,43).
ATP-induced dissociation of the acto-Myo1c1IQ alanine loop 1 chimeras
In the ATP-induced dissociation of acto-Myo1c the reaction remains biphasic for all the alanine
loops (the transient for Myo1c1IQ-8A is shown in Figure 3A) with the ratio of amplitudes
independent of ATP concentration and a dominating slow phase. In the absence of calcium the
fast phase was ∼10% of the total amplitude for each construct and the addition of calcium
reduced the fast phase by a factor of 2 at most, but since fast phase amplitudes are hard to
define with precision the change is not significant. The kmax for the fast phase (k+2) in the
absence of calcium was unaffected by the change in the alanine loops (<20% reduction; Figure
3C). In the presence of calcium (data not shown) the 8A construct was unaffected, while the
E/A (2-fold) and the R/A (5-fold) did show some acceleration of the reaction compared to WT.
The slow phase kmax (k+α) was unaffected in the absence (Figure 3D) or presence of calcium
except for the R/A construct which showed a 2-fold acceleration in the both the presence and
absence of calcium. The results are summarised in Table 1.
Effect of ADP on the ATP-induced dissociation of acto-Myo1c1IQ alanine loop 1 chimeras
To obtain an estimate of the affinity of ADP for acto-Myo1c for the loop 1 chimeras, the
dissociation by ATP was monitored with increasing concentrations of ADP present (either by
pre-incubating ADP with the protein or the ATP). Both experimental approaches produced
biphasic transients for all mutants as observed with Myo1c1IQ-WT (14), in both the presence
and absence of ADP. If ADP binding is in rapid equilibrium with A.M and A.M′ the two
experimental approaches will give the same results. This was true on the timescale of the slow
phase, but not for the fast phase. The analysis of each phase will therefore be dealt with
separately below. Typical pyrene fluorescence transients for the ATP-induced dissociation of
acto-Myo1c1IQ in the absence and presence of high ADP concentration (preincubated with
acto-Myo1c) are shown in Figure 4A for Myo1c1IQ-R/A (-Ca2+) and 4B for Myo1c1IQ-phasic
(+Ca2+).
Slow phase
If ADP is in rapid equilibrium with acto-Myo1c1IQ on the time scale of the measurement, the
two assays will give identical results for the kobs of the slow phase (Figure 4C). As the ADP
concentration was increased, the kobs of the slow phase, which monitors the A.M′ species, was
slowed for all constructs in a manner similar to that observed for Myo1c1IQ-WT, both in the
absence and presence of calcium. Hyperbolic fits provided the apparent ADP affinities
(Kapp) from which the KAD were calculated. The alanine constructs all showed similar Kapp
and KAD values as Myo1c1IQ-WT, both in the absence (Figure 4C) and presence of calcium
(with 10-fold weaker affinities in calcium; Figure 4D). The KAD values are summarised in
Table 2.
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When ADP was pre-incubated with acto-Myo1c1IQ the already small amplitude of the fast
phase disappeared rapidly as ADP was added and no trace of a fast phase was determined at
ADP > 5 μM, both with and without calcium making the analysis of the fast phase results
unreliable in this experimental approach (see Figure 4A and 4B). This is consistent with the
low values of KAD calculated above and listed in Table 2.
When ADP was pre-incubated with ATP and then rapidly mixed with acto-Myo1c1IQ the
kobs of the fast phase increased linearly with increasing ADP concentration. This diagnostic
of a competition between ADP and ATP for the binding to acto-Myo1c1IQ provides the 2nd
order rate constant of ADP binding (slope = k-AD) (data not shown). The R/A and E/A
constructs had similar k-AD values as WT (∼1 μM-1s-1), while the 8A construct was 2-fold
faster at 2.4 μM-1s-1. The experiment could only be completed reliably in the absence of
calcium (the fast phase could not be determined reliably in calcium due to the small
amplitudes).
Calculation of the ADP release constants (k+AD) from the KAD and ADP-binding rate constants
in the chimeras in the absence of calcium showed values similar to those found for
Myo1c1IQ-WT at ∼2 s-1 for Myo1c1IQ-R/A and Myo1c1IQ-E/A and slightly faster rate
constants at ∼4-5 s-1 for Myo1c1IQ-8A (Table 2). In the presence of calcium, the ADP release
rate constant for Myo1c1IQ-WT was accelerated ∼10-fold to 20 s-1, while the values calculated
for the alanine chimeras were accelerated between 5-7-fold (Table 2).
ATP-induced dissociation of acto-Myo1c1IQ-tonic,-Myo1c1IQ-phasic and -Myo1c1IQ-G
When the ATP-induced dissociation of acto-Myo1c was performed with Myo1c1IQ-tonic,
Myo1c1IQ-phasic and Myo1c1IQ-G in the absence of calcium, the observed amplitudes were
smaller than seen with Myo1c1IQ-WT. The amplitudes in the absence of calcium of
Myo1c1IQ-phasic were as little as 1/5th of those for Myo1c1IQ-WT, with 1.6 and 18 % for fast
and slow phases, respectively. The smaller amplitudes make defining the maximal rate
constant, k+2, of the fast phase difficult. Despite the loss in total amplitude, the value for Kα
for Myo1c1IQ-phasic was similar to Myo1c1IQ-WT at 0.09 (Table 1) and this increased to 0.23
in the presence of calcium. The amplitudes obtained for Myo1c1IQ-tonic were ∼7 % and ∼32
% of total fluorescence, for the fast and slow phases respectively, giving a value of Kα of 0.21
in the absence of calcium and this decreased to 0.12 in the presence of calcium. The observed
transients for Myo1c1IQ-G are shown in Figure 3B and in the absence of calcium only a single
phase could be distinguished with an amplitude of 13%. In the presence of calcium the slow
phase had an amplitude of 13 %, while the fast-phase amplitude was 33 %, giving Kα a value
of 1.8 in the presence of calcium. Table 1 gives the values of Kα for all the loop 1 chimeras in
the presence and absence of calcium.
The kobs values for the fast and slow phase of the ATP-induced dissociation in the absence of
calcium for Myo1c1IQ-tonic, Myo1c1IQ-phasic and Myo1c1IQ-G are shown in the secondary
plots in Figures 3E and 3F. The plots for all constructs show hyperbolic dependence of the
observed rate constants of the fast and slow phase on the ATP concentration. Hyperbolic fits
of the data gave values for k+α (slow phase) for Myo1c1IQ-tonic of 15 s-1, ∼8-fold faster than
with Myo1c1IQ-WT, while k+2 (fast phase) was slightly faster at 51 s-1. In the presence of
calcium the value for k+α was unchanged for Myo1c1IQ-tonic, while k+2 was 2-fold faster than
without calcium. In Myo1c1IQ-phasic, k+α and k+2 were similar to Myo1c1IQ-WT at ∼2 s-1 and
∼50 s-1, respectively (Figure 3E). When calcium was present the value of k+α was reduced to
1.0 s-1, while k+2 could not be determined reliably due to the very low amplitude. For
Myo1c1IQ-G the single-phase kobs showed hyperbolic dependence on ATP concentration with
a kmax of ∼18 s-1 in the absence of calcium. In the presence of calcium the major phase had a
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nearly identical kmax at 17.8 s-1 and a kmax at 5.7 s-1 for the slow component (data not shown).
Assignments for the two phases for Myo1c1IQ-G construct are not unambiguous since only a
single phase is observed in the absence of calcium. In the presence of calcium two phases are
observed and so the kmax for the fast phase is assigned to k+2 and the kmax of the slow phase
to k+α as previously. The single phase observed in the absence of calcium is problematic. It
could be that Kα is <0.1 and so no fast phase is observed and thus the kmax value represents
k+α = 17 s-1. This is much faster than any other value of k+α observed (<4 s-1), except that of
Myo1c1IQ-tonic (14 s-1). Alternatively k+α and k+2 are of the same order and the two phases
cannot be resolved. We assign both values of 17 s-1 with Kα unresolved until we have further
information. The values for k+2 and k+α for all chimeras in the presence and absence of calcium
are summarized in Table 1.
Effect of ADP on the ATP-induced dissociation of acto-Myo1c1IQ-tonic, -Myo1c1IQ-phasic and
-Myo1c1IQ-G
To obtain an estimate of the affinity of ADP for acto-Myo1c1IQ of the smooth muscle myosin
II and G-chimeras, the slow phase kobs of the two experimental approaches (displacement and
competition) were also plotted together as a function of ADP concentration and fitted to
hyperbolae (Figure 4). The values of Kapp in the absence of calcium for Myo1c1IQ-tonic and
Myo1c1IQ-phasic were similar to WT at 22 μM (Figure 4E). When calcium was present the
apparent affinity was weakened ∼10-fold for Myo1c1IQ-tonic (similar to WT), while
Myo1c1IQ-phasic, had an ∼ 2-fold weaker Kapp of 390 μM (Figure 4F). Since the Kα values
of tonic and phasic were affected differently by the presence of calcium, the KAD were very
different as well: Myo1c1IQ-phasic was similar to WT at 1.8 μM (-Ca2+) and was weakened
40-fold by calcium, while the KAD of Myo1c1IQ-tonic only weakened 5-fold (from ∼4 μM to
∼18 μM).
Unlike Myo1c1IQ-tonic and Myo1c1IQ-phasic, the kobs of Myo1c1IQ-G at 0 μM ADP was 8-
fold faster than for Myo1c1IQ-WT and the apparent ADP affinity was at 48 μM, 2-fold weaker
than for Myo1c1IQ-WT (Figure 4E). When calcium was present Myo1c1IQ-G did not produce
usable data. Only single exponential transients were obtained, the rates and amplitudes of which
showed little or no sensitivity to the concentration of ADP present, even at 250 μM, indicating
only very weak affinity for ADP. The 2nd order ADP-binding rate constants determined from
the fast phase kobs for Myo1c1IQ-tonic was similar to WT at 1.3 μM-1s-1; however, the ADP-
binding rate constant could not be determined for Myo1c1IQ-phasic or Myo1c1IQ-G because
the amplitudes of the fast phase were too small (for the purposes of the calculation we have
assumed the value of k-AD of these constructs is similar to that of the other constructs at ∼ 1.0
μM-1s-1).
The ADP release constants (k+AD) calculated from the KAD and ADP-binding rate constants
showed values in the absence of calcium for Myo1c1IQ-phasic similar to those found for
Myo1c1IQ-WT and slightly faster rate constants for Myo1c1IQ-tonic and Myo1c1IQ-G at ∼4-5
s-1 (Table 2). In the presence of calcium, the ADP release rate constant for Myo1c1IQ-tonic
showed only a 4-fold acceleration from 5 to 23 s-1 (WT was accelerated ∼ 10-fold) and
Myo1c1IQ-phasic showed more than a 30-fold accelerated rate constant for ADP release in
calcium (due to its much weaker KAD in the presence of calcium). No data could be obtained
for Myo1c1IQ-G in calcium.
Nucleotide binding and release from the Myo1c1IQ alanine loop 1 chimeras
The tryptophan fluorescence transients of ATP binding to the Myo1c1IQ alanine loop 1
chimeras in the absence of actin were described by a single exponential with similar amplitudes
as for WT (5-7 % reduced to 3-5 % in calcium; Figure 5A). The alanine loop constructs showed
the same hyperbolic dependence of the kobs as WT, both in the absence and presence of calcium,
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with kmax (=k+3+k-3) values of ∼45 s-1, inhibited 6-8-fold when calcium was present (Table
3). In the presence of calcium the values of k+α (∼3 s-1, Table 1) and k+3+k-3 (∼6 s-1) are
similar, raising the possibility that k+α is limited by a similar process as k+3+k-3. However,
only k+3+k-3 is sensitive to calcium suggesting that they are not similar events.
Displacement of ADP from the Myo1c1IQ loop 1 chimeras by ATP was biphasic with
amplitudes showing the same hyperbolic dependence on the ADP concentration present as
reported previously for WT. The fast phase represents ATP binding to free Myo1c and the slow
phase represents Myo1c with a bound ADP that must be released before ATP can bind (as
shown in Figures 6A, 6B for Myo1c1IQ-8A). Hyperbolic fits of the amplitudes found similarly
tight ADP affinities (5-6 μM) for the alanine constructs as reported for WT (3.3 μM) (14). The
kobs of the slow phase, representing the rate constant of ADP release (k+D), were again similar
in the alanine constructs and WT at ∼6 s-1. In the presence of calcium the fast and slow phase
could not be resolved, indicating that calcium slows ATP binding to a similar value as the rate
constant of ADP release, but leaving k+D independent of calcium at ∼4 s-1 (Table 2).
ATP binding to Myo1c1IQ-tonic, Myo1c1IQ-phasic and Myo1c1IQ-G in the absence of actin
ATP binding to Myo1c1IQ-tonic, Myo1c1IQ-phasic and Myo1c1IQ-G differed from the results
obtained with Myo1c1IQ-WT and the alanine chimeras in so far that the transients of the tonic,
phasic and G constructs displayed evidence of a small additional slow phase upon ATP binding
in the absence of calcium, but not in its presence (as observed in Myo1c1IQ-WT). Figure 5B
shows typical transients observed upon binding of 1 mM ATP to Myo1c1IQ-G in the absence
and presence of calcium. The origin of this additional slow phase is unknown and could not
be resolved any further in Myo1c1IQ-tonic and Myo1c1IQ-phasic due to the very small
amplitude (< 0.5 %). The kmax values obtained for the fast phase of these chimeras were 1.5-2-
fold faster than found for the wild type, both in the absence and presence of calcium, as shown
in the secondary plots of ATP binding in Figures 5C and 5D, respectively (see also Table 3).
The 1/K1 values were 75-100 μM for the three chimeras, half the value observed for
Myo1c1IQ-WT. Addition of calcium reduced 1/K1 ∼3-fold for Myo1c1IQ-tonic (similar in value
to Myo1c1IQ-WT) and much less for Myo1c1IQ-phasic and Myo1c1IQ-G. The presence of
calcium reduced the kmax 4-5 fold for Myo1c1IQ-tonic and Myo1c1IQ-phasic and ∼6 fold for
the Myo1c1IQ-G, similar to the wild-type results (see Table 3). In the case of Myo1c1IQ-G the
second phase was reasonably well resolved, both in the absence and presence of calcium, with
an amplitude of ∼1.5 % and kmax value of ∼9 s-1 and ∼3 s-1, respectively. It is assumed here
that the fast phase corresponds to the hydrolysis rate constant observed for the other chimeras,
since the amplitude is of a similar size (6 %) and behaves in the same manner with K0.5 and
K1k+2 values comparable to the tonic and phasic chimeras. However, the binding of ATP to
many myosins occurs in two distinct steps, first the partial closing of switch II, accompanied
by an enhancement in tryptophan fluorescence (reported by W510 in skeletal muscle myosin
II and W433 in Myo1c), followed by the hydrolysis step, which fully closes switch II (44, 45).
In most myosins this first step cannot be resolved experimentally. The two phases observed
here in Myo1c1IQ-G on ATP binding could therefore represent these two reaction steps: switch
II closing at ∼80 s-1 (fast phase) followed by much slower hydrolysis at ∼10 s-1 (slow phase).
ADP displacement from Myo1c1IQ-tonic, Myo1c1IQ-phasic and Myo1c1IQ-G
When ADP was displaced from Myo1c1IQ-tonic, Myo1c1IQ-phasic and Myo1c1IQ-G by a large
excess of ATP the results differed from those of the WT and the alanine constructs. In the
absence of calcium the tryptophan transients of ADP displacement from these chimeras were
also described by two exponentials (as observed for WT), however the amplitude changed for
these constructs as ADP was increased. For Myo1c1IQ-tonic pre-incubation with increasing
ADP concentrations in the absence of calcium reduced the total amplitude of the tryptophan
fluorescence transient from 5% to 2-3%. The fast amplitude (with kobs = ∼80 s-1) decreased
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towards zero and could be described by a hyperbola with a KD of 9.2 μM (Figure 6C). The
amplitude of the slow phase was too small (<2%) to allow reliable analysis of the concentration
dependence, but the kobs (= k+D) was ∼7 s-1, similar to that seen with Myo1c1IQ-WT. The tonic
loop therefore weakens the affinity of Myo1c for ADP 3-fold compared to Myo1c1IQ-WT in
the absence of calcium, but has little effect on the rate constant for ADP release (k+D).
For Myo1c1IQ-phasic the total observed amplitude of the reaction was too small (2-3%) to
allow the two phases to be distinguished from each other, hence no KD could be determined.
However, working at very high ATP concentration (10 mM) in the presence of 50 μM ADP,
the ADP release rate constant (k+D) from Myo1c1IQ-phasic could be measured as 37 s-1
(compared to 60 s-1 for k+3+k-3) with an amplitude of 2%. The results are consistent with a
relatively weak affinity of ADP for Myo1c1IQ-phasic and a 6-fold faster ADP-dissociation
constant compared to Myo1c1IQ-WT.
The addition of 0.5 mM ATP to Myo1c1IQ-G showed two phases in the tryptophan fluorescence
transient even in the absence of ADP as shown in the secondary plots of Figure 5C. Pre-
incubating Myo1c1IQ-G with ADP (2-100 μM) resulted in the kobs of the fast phase slowing
from 71 s-1 (at zero ADP) to ∼25-30 s-1 (at high ADP, as shown in Figure 6D) and this slowing
of the observed rate constant was accompanied by a loss in amplitude of the fast phase from 6
to ∼ 4 %. The slow-phase kobs and amplitudes were not very well defined (∼2.5 %), but neither
showed any sensitivity to ADP. A hyperbolic fit of the fast-phase kobs values gave a K0.5 of
7.9 ± 3.0 μM. This result is indicative of a different type of mechanism at work in Myo1c1IQ-
G. The data are compatible with an ADP affinity of ∼8 μM and an ADP-release rate constant
(k+D) of 25-30 s-1, indicating that displacement of ADP from myosin is at fast equilibrium
compared to ATP binding in this chimera.
Repeating the ADP displacement measurement in the presence of calcium was limited by the
small amplitudes of the transients with Myo1c1IQ-phasic and Myo1c1IQ-G and was only
possible for Myo1c1IQ-tonic (Figure 7). As the ADP concentration was increased from 0 to 50
μM the observed fast-phase amplitude of Myo1c1IQ-tonic decreased from ∼5 % to 1 % (Figure
7B) and at the same time the kobs slowed from ∼13 to 4 s-1 (Figure 7A). A hyperbolic fit of
the kobs and amplitude data gave K0.5 values of ∼18 and 11 μM, respectively. Increasing the
ATP concentration to 10 mM (with ADP at 50 μM) gave an unchanged amplitude and a kobs
of 18 s-1 (similar to the kmax for ATP binding) suggesting that the ADP-release rate constant
(k+D) is greater than 18 s-1 in the presence of calcium. This suggests that the displacement of
ADP from Myo1c1IQ-tonic is at fast equilibrium compared to the maximal rate constant of
ATP binding (on the timescale of the measurement) and the ADP affinity of Myo1c1IQ-tonic
is weakened up to 2-fold in calcium, resulting in a 2-fold acceleration of the ADP-release rate
constant. This behaviour stands in contrast to results obtained for the alanine chimeras or
Myo1c1IQ-WT, where the KD appeared little changed by calcium (Table 2).
Steady-state ATPase activity
As previously observed (7,14,42) the basal ATPase of Myo1c is very low (≪ 0.1 s-1) and
relatively insensitive to calcium. The Myo1c1IQ constructs show similar low basal ATPase
except for Myo1c1IQ-phasic and Myo1c1IQ-G which had elevated basal ATPase activity at
high, but not low, calcium concentrations with V0 values of 0.23 and 0.48 s-1, respectively.
The steady-state actin-activated Mg2+-ATPase activity of Myo1c1IQ-WT is shown in Figure
8. The ATPase activity was relatively low with little calcium sensitivity over the range of pCa
4.6 - 8.9 (Vmax 2 ± 0.26 s-1 at pCa 4.6; 1.8 ± 0.19 s-1 at pCa 8.9). All of the mutants were
activated with increasing amounts of actin and their behaviour was not dramatically different
from Myo1c1IQ-WT. Exceptions were that the Vmax of Myo1c1IQ-tonic was higher than
Myo1c1IQ-WT at 3.36 ± 0.08 s-1 and the Km of Myo1c1IQ-G at 0.28 ± 0.04 μM at pCa 4.6 was
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70-fold lower than Myo1c1IQ-WT (20 ± 7 μM) and Myo1c1IQ-phasic with very low Vmax and
Km values.
The same trend was observed for the constructs with 2 IQs and an incorporated SAH domain
(data not shown) indicating that modification of the LCBD by incorporation of a single α-helix
did not adversely affect the enzymatic activity of the Myo1c motor domain.
In vitro translocation of actin by Myo1c mutants
The yield of expressed protein from insect cells for the 1-IQ forms of Myo1c exceeds that of
expressed full-length Myo1c in our hands; however, the light-chain-binding domain (LCBD),
which acts as a lever arm and therefore affects the maximum rate of motility (46), is short in
the 1-IQ form. To investigate the ability of the Myo1c loop 1 mutants to translocate actin
filaments in vitro, we prepared fusion proteins of wild-type Myo1c and the loop 1 mutants,
phasic, tonic and G, with a recently recognized structural element found in myosin X. Myosin
X contains a 36-residue sequence that forms a single α-helix (or SAH) (47). We reasoned that
addition of the SAH domain to the LCBD of Myo1c would act as an extended artificial lever
arm much the same way that α-actinin repeats do (47) and make the constructs suitable for use
in in vitro motility assays. In 1 mM EGTA Myo1cSAH-WT translocated actin filaments at 12
± 4 nm/sec (353 filaments) (Table 4). This is not inconsistent with the previously determined
rate for baculovirus-expressed full-length rat Myo1c of 30 nm/sec (48). The motility of
Myo1cSAH-WT was twice the rate of Myo1cSAH-phasic (5 ± 3 nm/sec, 318 filaments) and
about half that of Myo1cSAH-tonic (22 ± 7 nm/sec, 587 filaments) and Myo1cSAH-G (29 ± 7
nm/sec, 455 filaments). The data should be viewed as preliminary because the ideal splicing
point for fusing the IQ domain with the SAH domain has not yet been explored; however, the
values for Vmax of the ATPase data for these constructs show the same relationship and were
about 70% of the values listed in Figure 8 for the 1IQ constructs.
Discussion
In this study we investigated the role of loop 1 in defining the biochemical properties of Myo1c.
Loop 1 influences the rate constant of ADP release in a number of different myosins and the
nature of the ADP release from acto-myosin is a key element in defining the mechano-chemical
characteristics of myosins (23,26,27). For example, ADP release is coupled to a small swing
of the motor domain in the same direction as the Pi-coupled power stroke of several myosins
and this is thought to be central to the load sensitivity of the ADP-release step (5,37,38,49).
ADP release has also been proposed to limit the velocity of low duty ratio myosins, where it
does not limit the ATPase cycle (17). In the case of Myo1c we have recently shown that ADP
release is also calcium sensitive, thereby providing a mechanism in which calcium could alter
the duty ratio of this myosin (14). Thus, understanding how the ADP-release rate is defined
for a given myosin is a core issue in understanding the mechano-chemistry of each myosin. In
addition, if a simple way to modulate the ADP release by small changes in the sequence of
loop 1 could be defined, these same myosins could be expressed in mice to test how mechano-
chemical properties are modulated in vivo. The results presented here show that modifying
loop 1 alters the ADP-release characteristics of Myo1c; however, as for myosin II the resulting
properties cannot be easily predicted from sequence alone.
We show here that the length of loop 1 may be important as suggested previously (26) whereas
exchanging residues in loop 1 for alanine residues, individually or as a group of 8, had very
little effect on any of the parameters measured here including calcium sensitivity. In most cases
the measured parameters were within 10-20% of the wild-type values. The exceptions were
the ATPase Vmax values of Myo1c1IQ-8A, which were ∼40 % higher at both high and low
calcium and the rate constant of ADP release from A.M.D, k+AD, which was elevated by ∼2
fold in the absence of calcium. This increase in k+AD is consistent with ADP release being rate
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limiting for the ATPase cycle at low calcium. In contrast, the rate constant for the ATP
hydrolysis step of Myo1c1IQ-8A, which is considered to be partially rate limiting for the
ATPase cycle in the presence of calcium, was altered <10% compared to WT.
Overall, the alanine constructs provided little evidence of a specific role of the amino acid side
chains in the wild-type loop 1, even for the proline side chains, which are expected to provide
restricted flexibility in the loop structure. In contrast, shortening the loop to a single glycine
or extending it with the longer loops found in smooth muscle myosin II produced significant
changes in the behaviour of the constructs.
The best behaved mutant of the second group of constructs – in that it showed no major
alteration in overall properties - was Myo1c1IQ-tonic. For this construct the Km for actin values
was relatively unaffected, but Vmax values were elevated by ∼30% at low calcium and almost
2-fold at high calcium (Figure 8). A similar increase of ∼2-fold was also observed for the
velocity of the SAH constructs in motility assays (Table 4). If the hydrolysis rate constant is
contributing to limiting the Vmax values at high calcium in Myo1c1IQ-tonic, then an increase
in the rate constant of the hydrolysis step (k+3+k-3) is expected and a 2.5-fold increase was
indeed observed. The increase in the rate constant of the hydrolysis step (k+3+k-3) was smaller
at low calcium at ∼ 60 %. The increase in the rate constant of hydrolysis at high calcium is
consistent with a contribution of the hydrolysis step to the ATPase activity; however, this is
unlikely to be direct since the hydrolysis rate constant is ∼ 5 times the Vmax value for this
construct even at high calcium (3 times for WT).
At low calcium the ADP-release rate constant is thought to limit the ATPase activity. Whereas
the ADP release rate constant (k+AD) and the Vmax were similar for the WT, the ADP release
for Myo1c1IQ-tonic was up to twice the value of the Vmax (and a little less in the presence of
calcium). This difference is made clear when the ratio of the k+AD/(k+3+k-3) in the absence of
calcium for WT and tonic (2.1/44 = 0.048 and 4.9/72.3 = 0.067, respectively) is compared with
the same values in the presence of calcium (20.3/6.3 = 3.2 and 23/15 = 1.53, respectively).
Other differences in the kinetic parameters determined for Myo1c1IQ-tonic were variable.
Notable is that the k+α values were 5-fold faster with little impact on Kα and the ADP affinity
for myosin (without actin) was 3-fold weaker with little effect on the rate constant of ADP
release (k-D). The Myo1c1IQ-phasic construct had a higher basal ATPase, lower Vmax values
(30-50% of WT), and the velocities measured in the motility assays were also about 50% of
the WT (25% of those of the tonic construct) (see Figure 8 and Table 4). It should be noted
that many of the transient kinetic parameters measured here were much harder to evaluate for
Myo1c1IQ-phasic since the amplitudes of the fluorescence changes were much smaller in most
cases. Note that in the absence of actin, the affinity of ADP for myosin could not be determined,
while the hydrolysis step (-Ca2+) was 1.5- to 2-fold faster, despite a lower Vmax. In the presence
of actin k+α and Kα were not strongly affected by calcium, while the KAD in the presence of
calcium was weakened 5-fold, but no change was observed in the absence of calcium. This is
interpreted as a large (4-5-fold) increase in k+AD, which only occurs in the presence of calcium.
For the Myo1c1IQ-G construct the basal ATPase was also higher, although the Vmax values
were similar to WT with a much lower apparent affinity for actin. The unchanged Vmax values
were not reflected in the motility data, which showed 2.5-fold faster velocities than WT (see
Figure 8 and Table 4). Other major changes for Myo1c1IQ-G were a biphasic fluorescence
change in the absence of actin, while single-phase fluorescence transients were observed in the
presence of actin (-Ca2+).
In summary, each of these three constructs showed a distinct set of properties and no general
pattern was observed. All of the properties assayed here are therefore potentially modulated,
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either directly or indirectly, by the structure of the loop 1. A similar set of constructs in the
Myo1b backbone also resulted in a wide range of distinct responses, albeit differing to the ones
observed here with Myo1c1IQ (22). The native loops of Myo1b and Myo1c are of similar size
but different sequence (Figure 1A). In the Myo1b backbone the loss of either charged residue
or the change to a series of alanine residues gave distinct properties to the myosin, including
changes to Kα, KAD and the calcium sensitivity of the two parameters. That the effects of a
mutation in one myosin do not necessarily correlate with the same mutation in different
backgrounds has been seen with other myosins, notably in a recent study of the R403Q mutation
in myosin II, which is associated with familial cardiomyopathy (31). This is also true of loop
1 in smooth muscle myosin II where the longer phasic loop 1 is associated with a weaker ADP
affinity in the presence of actin (KAD) and a faster velocity of muscle shortening (26). Here
we observe little difference in KAD in the absence of calcium (2-fold tighter for phasic than
tonic), but 5-fold weaker for phasic in the presence of calcium. In Myo1b the phasic loop gave
a 2-fold tighter KAD (2 μM) than for tonic (5.8 μM) in the presence of calcium and the difference
disappeared in the absence of calcium, where for both tonic and phasic loops the KAD affinity
was very tight at 0.7 μM.
Thus we conclude that for the surface loops explored to date, the parent myosin dominates the
behaviour and loop 1 modulates the properties of the parent myosin. The loops themselves do
not confer predictable properties on the parent myosin and their roles can only be defined in
the context of the myosin. This is consistent with the loop altering the connecting structural
elements (the helices connecting to the P-loop and switch I) and thereby modulating the myosin
behaviour, rather than the loop having specific interactions with other parts of the myosin
molecule.
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PCR polymerase chain reaction
Pyrene pyr, N-(l-pyrenyl) iodoacetamide
SAH single alpha helix
T ATP
WT wild type
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A, sequence alignment of the loop 1 region (underlined) in the myosin head starting with the
P-loop (bold) and ending after switch-1 (bold). Shown are the sequences of rat Myo1c,
Dictyostelium MyoE, rat Myo1b, chicken phasic smooth muscle myosin II, rabbit tonic smooth
muscle myosin II and Dictyostelium myosin II. Secondary structure assignments were made
using the structure of the motor domain of Dictyostelium MyoE (1LKX) as a guide. Symbols:
*, residues identical in all sequences; :, conserved substitutions; ., semi-conserved
substitutions; H, helical region. B, list of loop 1 constructs used in study.
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ATP-induced dissociation of pyr.acto-Myo1c1IQ-WT in the absence and presence of calcium.
Plots of the fast phase kobs of the pyrene fluorescence transient as a function of ATP
concentration (with and without calcium). Data were fitted to a hyperbolae to obtain kmax and
K0.5 values: -Ca2+: kmax = 41.2 ± 2.3 s-1, K0.5 = 0.51 ± 0.1 mM; +Ca2+: kmax = 19.6 ± 4.1
s-1, K0.5 = 1.66 ± 1.0 mM.
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ATP-induced dissociation of pyr.acto-Myo1c1IQ. Pyrene fluorescence transients observed
upon mixing 25 nM pyr.actin-Myo1c1IQ chimeras with 1 mM ATP in the absence and presence
of calcium. A, transients for Myo1c1IQ-8A fitted to two exponentials (best fits superimposed):
-Ca2+: kobs1 = 20.8 s-1, A1 = 4.6 %, kobs2 = 1.4 s-1, A2 = 44.2 %; +Ca2+: kobs1 = 11.8 s-1, A1
= 2.6 %, kobs2 = 1.3 s-1, A2 = 36.8 %. B, transients for pyr.actin-Myo1c1IQ-G. The −Ca2+
transient was fitted to one exponential, the +Ca2+ transient to two exponentials (best fits
superimposed): -Ca2+: kobs = 7.9 s-1, A = 15.0 %; +Ca2+: kobs1 = 6.1 s-1, A1 = 31.1 %, kobs2
= 1.6 s-1, A2 = 14.8 %. C – F, plots of the fast phase (C & E) and slow phase (D & F) kobs for
the chimeras as a function of [ATP] in the absence of calcium. Data were fitted to hyperbolae
to obtain kmax and K0.5 values: C & D, WT and alanine chimeras: C, fast phase kmax = 41±2
s-1 (WT ■), 41 ± 3 s-1 (R/A ○), 35 ± 1 s-1 (E/A ▲) and 34 ± 1 s-1 (8A ∇); K0.5 = 507 ± 97
μM (WT), 622 ± 182 μM (R/A), 854 ± 75 μM (E/A) and 644 ± 57 μM (8A). D, slow phase:
kmax = 2.0 s-1 (WT ■), 4.3 s-1 (R/A ○), 2.8 s-1 (E/A ▲) and 2.0 s-1 (8A ∇); K0.5 = 370 ± 33
μM (WT), 623 ± 47 μM (R/A), 626 ± 11 μM (E/A) and 506 ± 18 μM (8A). E & F, smooth
muscle loop and G chimeras: E, fast phase : kmax = 41 ± 2 s-1 (WT ■), 51 ± 2 s-1 (tonic ◆),
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∼49 ± 7 s-1 (phasic ◁); K0.5 = 507 ± 97 μM (WT), 445 ± 49 μM (tonic), 1342 ± 479 μM
(phasic). F, slow phase: kmax = 2.0 s-1 (WT ■), 14.6 s-1 (tonic ◆), 1.5 s-1 (phasic ◁) and 17.8
s-1 (G ▶); K0.5 = 370 ± 33 μM (WT), 447 ± 13 μM (tonic), 468 ± 34 μM (phasic) and 888 ±
230 μM (G).
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Effect of ADP on ATP-induced dissociation of pyr.acto-Myo1c1IQ. (A & B), pyrene
fluorescence transients of 25 nM pyr-acto-Myo1c1IQ mixed with 250 μM ATP in the stopped-
flow apparatus in the absence or presence of high ADP for Myo1c1IQ-R/A (-Ca2+) and
Myo1c1IQ-phasic (+Ca2+). Transients in the absence of ADP were fitted to 2 exponentials,
transients in the presence of ADP were fitted to a single exponential: A, R/A: -ADP: kobs1 =
11.0 s-1, A1 = 3.0 %, kobs2 = 1.3 s-1 A2 = 51.3 %; +ADP: kobs = 0.3 s-1, A = 52.8 %. B, phasic:
-ADP: kobs1 = 16.6 s-1, A1 = 0.8 %, kobs2 = 0.3 s-1, A2 = 6.0 %; +ADP: kobs = 0.9 s-1, A = 6.4
%. C to F, Increasing concentrations of ADP were either incubated with pyr.acto-Myo1c1IQ
or ATP and the transients were fitted to two exponentials. The kobs of the slow phases of both
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experimental approaches was plotted together and fitted to a hyperbola to determine Kapp and
k0 (in the absence (C & E) and presence of calcium (D &F). C & D, alanine chimeras: -
Ca2+: Kapp = 16.7 ± 1.9 μM (WT ■), 22.5 ± 2.9 μM (R/A ○), 17.0 ± 1.7 μM (E/A ▲), 20.3 ±
1.9 μM (8A ∇); k0 = 0.82 s-1 (WT), 1.16 s-1 (R/A), 0.76 s-1 (E/A), 0.62 s-1 (8A); +Ca2+:
Kapp = 173.6 ± 17.0 μM (WT), 166.1 ± 12.6 μM (R/A), 172.6 ± 30.3 μM (E/A), 180.0 ± 17.4
μM (8A); k0 = 0.51 s-1 (WT), 0.91 s-1 (R/A), 0.59 s-1 (E/A), 0.55 s-1 (8A). (E & F), smooth
muscle myosin II loop 1 and G chimeras: -Ca2+: Kapp = 16.7 ± 1.9 μM (WT ■), 21.9 ± 4.2
μM (tonic ◆), 22.0 ± 3.5 μM (phasic ◁), 47.6 ± 6.3 μM (G▶); k0 = 0.82 s-1 (WT), 5.5 s-1
(tonic), 0.87 s-1 (phasic), 6.2 s-1 (G); +Ca2+: Kapp = 173.6 ± 17.0 μM (WT), 165.2 ± 24.3 μM
(tonic), 390.6 ± 46.1 μM (phasic); k0 = 0.51 s-1 (WT), 4.92 s-1 (tonic), 0.27 s-1 (phasic), (no
data for G).
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ATP binding to Myo1c1IQ loop 1 chimera. A & B, Protein fluorescence transients observed
upon mixing 50 nM Myo1c1IQwith 1 mM ATP in the absence and presence of calcium
(concentrations after mixing). Data were fitted to a single exponential (best fit superimposed):
A, Myo1c1IQ-R/A -Ca2+: kobs = 41.6 s-1, A = 6.3 %; +Ca2+: kobs = 5.7 s-1, A = 5.8 %. B,
Myo1c1IQ –tonic: -Ca2+: kobs = 66.3 s-1, A = 4.5 %; +Ca2+: kobs = 13.5 s-1, A = 3.5 %. C &
D, kobs of each chimera plotted as a function of ATP concentration. Data were fitted to
hyperbolae (best fits superimposed): C, fitted values in the absence of calcium kmax = 44.3 ±
1.9 s-1 (WT ■), 72.8 ± 1.1 s-1 (tonic ◆), 61.1 ± 10.3 s-1 (phasic ◁), 9.1 ± 0.2 s-1 (G slow ▶),
82.5 ± 1.9 s-1 (G fast ▷); K0.5 = 184 ± 22 μM (WT), 94.5 ± 4.8 μM (tonic), 75 ± 30 μM (phasic),
100.0 ± 7.7 μM (G fast), 381 ± 102 μM (G slow). D, Fitted values in presence of calcium:
kmax = 6.3 ± 0.1 s-1 (WT), 15.0 ± 0.9 s-1 (tonic), 13.0 ± 0.7 s-1 (phasic), ∼3 s-1 (G slow), 13.1
± 1.4 s-1 (G fast); and K0.5 = 49.5 ± 3.4 μM (WT), 34.4 ± 9.9 μM (tonic), 52.0 ± 11.9 μM
(phasic), 100.3 ± 38.3 μM (G fast), 670 ± 295 μM (G slow).
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ADP displacement from Myo1c1IQ loop 1 chimeras in the absence of calcium. A, Protein
fluorescence transient observed upon displacing 10 μM ADP from 50 nM Myo1c1IQ-8A by
addition of 0.5 mM ATP. The change in fluorescence was fitted to two exponentials: kobs1 =
8.1 s-1, kobs2 = 2.3 s-1, A1 = 1.7 %, A2 = 5.1 %. B, Plot of the fast and slow amplitudes of the
ADP displacement experiment for Myo1c1IQ-8A as a function of [ADP]. The data were fitted
to a hyperbola to obtain the KD. KD, fast = 5.2 ± 0.8 μM, KD, slow = 5.7 ± 1.1 μM. C, plot of
the fast phase amplitude of the ADP-displacement experiment with Myo1c1IQ-tonic as a
function of [ADP]. A fit to a hyperbola defined KD = 9.2 ± 1.6 μM. D, plot of the fast phase
kobs of the ADP displacement experiment with Myo1c1IQ-G as a function of [ADP]. A fit to a
hyperbola defined KD = 7.9 ± 3.0 μM with k0 = 71 s-1.
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ADP displacement from Myo1c1IQ-tonic in the presence of calcium. 50 nM Myo1c1IQ-tonic
was incubated with increasing concentrations of ADP and then mixed with 0.5 mM ATP in
the stopped-flow system and the change in protein fluorescence monitored over time. A, plot
of the kobs as a function of [ADP]. The data of the fast phase were fitted to a hyperbola to
determine the KD = 18.2 ± 3.7 μM with k0 = 13.1 s-1. B, plot of the amplitude as a function of
[ADP]. A fit to a hyperbola determined the KD = 10.8 ± 4.2 μM.
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Steady-state actin-activated ATPase activity of Myo1c1IQ and loop 1 mutants. Plotted are the
values of Vmax (left) and Km (right) at pCa 4, 5, 6 and 8.9 for Myo1c1IQ-WT and each of the
loop 1 mutants used in the study.
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Table 4
Myo1cSAH-mediated movement of actin filaments in vitro*
Construct movement of actin in nm/s
Myo1cSAH-WT 12 ± 4 (353)
Myo1cSAH-tonic 22 ± 7 (587)
Myo1cSAH-phasic 5 ± 3 (318)
Myo1cSAH-G 29 ± 7 (455)
*
Data are presented as average speed ± standard deviation (number of filaments analyzed)
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